* Somalogic Inc SLGC.OQ reported a quarterly adjusted loss
of 18
cents per share for the quarter ended in September. The mean
expectation of four analysts for the quarter was for a loss
of 20 cents per share.
* Revenue was $41.71 million; analysts expected $20.08
million.
* Somalogic Inc's reported EPS for the quarter was a loss
of 18
cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Somalogic Inc shares had risen by 13.4% this quarter and
lost 71.7% so far this year.
* The company reported a quarterly loss of $32.94 million.
* Wall Street's median 12-month price target for Somalogic
Inc is
$8.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
14 at 04:40 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.20 -0.18 Beat
Jun. 30 2022 -0.18 -0.13 Beat
Mar. 31 2022 -0.16 -0.02 Beat
Dec. 31 2021 -0.13 -0.13 Met